The Food and Drug Administration is spending today listening to people whose wounds have not closed, at a public meeting designed to influence how future wound treatments are tested and what those trials must measure.
The hybrid public meeting on chronic wounds runs from 10 a.m. to 4:30 p.m. Eastern, online by webcast and in person at the agency's White Oak campus in Silver Spring, Maryland.
